
    
      The objective is to identify the utility of ultrasound as a screening test for endometrial
      hyperplasia and cancer in an "at risk" cohort. Endometrial carcinoma is an understudied
      cancer. This study will provide benefit regardless of its outcome, because it will be the
      first prospectively designed screening trial in an asymptomatic population.
    
  